Dechra Pharmaceuticals 관리
관리 기준 확인 4/4
Dechra Pharmaceuticals CEO는 Ian Page, Nov2001 에 임명되었습니다 의 임기는 22.17 년입니다. 총 연간 보상은 £ 1.04M, 59.9% 로 구성됩니다. 59.9% 급여 및 40.1% 보너스(회사 주식 및 옵션 포함). 는 £ 15.64M 가치에 해당하는 회사 주식의 0.36% 직접 소유합니다. 15.64M. 경영진과 이사회의 평균 재임 기간은 각각 4.8 년과 4.3 년입니다.
주요 정보
Ian Page
최고 경영자
UK£1.0m
총 보상
| CEO 급여 비율 | 59.9% |
| CEO 임기 | 22.2yrs |
| CEO 소유권 | 0.4% |
| 경영진 평균 재임 기간 | 4.8yrs |
| 이사회 평균 재임 기간 | 4.3yrs |
최근 관리 업데이트
Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31
A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2023 | UK£1m | UK£621k | -UK£28m |
| Mar 31 2023 | n/a | n/a | UK£6m |
| Dec 31 2022 | n/a | n/a | UK£40m |
| Sep 30 2022 | n/a | n/a | UK£49m |
| Jun 30 2022 | UK£2m | UK£597k | UK£58m |
| Mar 31 2022 | n/a | n/a | UK£66m |
| Dec 31 2021 | n/a | n/a | UK£73m |
| Sep 30 2021 | n/a | n/a | UK£64m |
| Jun 30 2021 | UK£3m | UK£551k | UK£56m |
| Mar 31 2021 | n/a | n/a | UK£50m |
| Dec 31 2020 | n/a | n/a | UK£44m |
| Sep 30 2020 | n/a | n/a | UK£39m |
| Jun 30 2020 | UK£2m | UK£517k | UK£34m |
| Mar 31 2020 | n/a | n/a | UK£31m |
| Dec 31 2019 | n/a | n/a | UK£29m |
| Sep 30 2019 | n/a | n/a | UK£30m |
| Jun 30 2019 | UK£3m | UK£500k | UK£31m |
| Mar 31 2019 | n/a | n/a | UK£28m |
| Dec 31 2018 | n/a | n/a | UK£25m |
| Sep 30 2018 | n/a | n/a | UK£30m |
| Jun 30 2018 | UK£3m | UK£500k | UK£36m |
| Mar 31 2018 | n/a | n/a | UK£40m |
| Dec 31 2017 | n/a | n/a | UK£43m |
| Sep 30 2017 | n/a | n/a | UK£35m |
| Jun 30 2017 | UK£3m | UK£490k | UK£26m |
보상 대 시장: Ian 의 총 보상 ($USD 1.31M ) UK 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 3.22M ).
보상과 수익: Ian 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Ian Page (62 yo)
22.2yrs
테뉴어
UK£1,037,000
보상
Mr. Ian D. Page has been the Chief Executive Officer and Managing Director of Dechra Pharmaceuticals Plc since November 2001 and 1998 respectively and also serves as its Executive Director since June 13, 1...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Executive Director | 22.2yrs | UK£1.04m | 0.36% £ 15.6m | |
| CFO & Executive Director | 4.8yrs | UK£641.00k | 0.010% £ 452.7k | |
| Chief Scientific Officer | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| Chief Information Officer | 1.6yrs | 데이터 없음 | 데이터 없음 | |
| Chief People Officer | no data | 데이터 없음 | 데이터 없음 | |
| President of North America | no data | 데이터 없음 | 데이터 없음 | |
| Company Secretary | 6.5yrs | 데이터 없음 | 데이터 없음 |
4.8yrs
평균 재임 기간
53yo
평균 연령
경험이 풍부한 관리: DPH 의 관리팀은 경험 ( 4.8 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Executive Director | 26.6yrs | UK£1.04m | 0.36% £ 15.6m | |
| CFO & Executive Director | 4.3yrs | UK£641.00k | 0.010% £ 452.7k | |
| Independent Non-Executive Director | less than a year | UK£36.00k | 데이터 없음 | |
| Senior Independent Director | 7.1yrs | UK£107.00k | 0.0052% £ 227.2k | |
| Independent Non-Executive Chairman | 3.8yrs | UK£207.00k | 0.0033% £ 143.6k | |
| Designated Non-Executive Director | 4.9yrs | UK£72.00k | 0.0012% £ 53.3k | |
| Independent Non-Executive Director | 1.6yrs | UK£73.00k | 0.00053% £ 23.3k |
4.3yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: DPH 의 이사회는 경험(평균 재직 기간 4.3 년)으로 간주됩니다.